02522.HK
Jiangxi Rimag Group Co., Ltd.
HKSE · Healthcare · Medical - Care Facilities · CN
HKD 5.14
−0.29%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.7B | 873.1M | 760.6M | 928.9M | 784.4M |
| Cost of Revenue | 1.2B | 577.9M | 483.3M | 596.3M | 547.5M |
| Gross Profit | 534.1M | 295.2M | 277.3M | 332.6M | 236.9M |
| Operating Expenses | |||||
| R&D Expense | 38.0M | 15.7M | 11.5M | 12.8M | 11.5M |
| SG&A Expense | 569.8M | 235.6M | 290.1M | 96.9M | 70.4M |
| General & Admin Expense | 285.2M | 172.6M | 223.6M | 48.2M | 34.8M |
| Selling & Marketing Expense | 96.4M | 63.0M | 66.4M | 65.6M | 35.7M |
| Other Expenses | 12.2M | (5.9M) | 2.8M | 150.6M | 116.1M |
| Total Operating Expenses | 619.9M | 245.4M | 304.4M | 260.4M | 198.0M |
| Cost and Expenses | 1.8B | 823.3M | 787.7M | 856.7M | 745.5M |
| Operating Income (EBIT) | (85.8M) | 49.8M | (27.1M) | 72.2M | 38.9M |
| Non-Operating | |||||
| Interest Income | 13.6M | 9.4M | 6.8M | 6.0M | 6.9M |
| Interest Expense | 52.7M | 28.7M | 25.3M | 24.8M | 37.3M |
| Net Interest Income | (39.1M) | (19.3M) | (18.5M) | (18.8M) | (30.5M) |
| Other Non-Op Income/Expense | 1.8M | (54.0M) | (24.2M) | (28.9M) | (38.0M) |
| Non-Operating Income (excl Interest) | 34.5M | 25.3M | (1.0M) | 4.1M | 676.0K |
| EBT (Pre-Tax Income) | (84.1M) | (4.2M) | (51.3M) | 43.4M | 935.0K |
| Income Tax Expense | 13.8M | 6.3M | 7.5M | 6.8M | 16.0M |
| Bottom Line | |||||
| Net Income | (59.7M) | 3.7M | (45.9M) | 44.4M | 364.0K |
| Earnings from Cont. Ops | (97.8M) | (10.5M) | (58.9M) | 36.6M | (15.1M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (59.7M) | 3.7M | (45.9M) | 44.4M | 364.0K |
| Per Share | |||||
| Basic EPS | (HK$0.16) | HK$0.01 | (HK$0.13) | HK$0.13 | HK$0.00 |
| Diluted EPS | (HK$0.16) | HK$0.01 | (HK$0.13) | HK$0.13 | HK$0.00 |
| Revenue Per Share | HK$4.43 | HK$2.44 | HK$2.18 | HK$2.74 | HK$2.32 |
| Shares | |||||
| Basic Shares Outstanding | 389.7M | 358.0M | 348.7M | 338.5M | 338.5M |
| Diluted Shares Outstanding | 389.7M | 358.0M | 348.7M | 338.5M | 338.5M |
| Profitability Metrics | |||||
| EBITDA | 253.6M | 223.5M | 169.3M | 256.2M | 207.9M |
| D&A | 373.9M | 199.0M | 195.4M | 188.0M | 169.6M |
| EBIT | (120.3M) | 24.5M | (26.1M) | 68.2M | 38.3M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026